Evaluation method of interferon beta treatment against multiple sclerosis
AssigneeHitachi, Ltd.
InventorsTakashi Yamamura, Jun-ichi Satoh, Toshiro Saito, Hiroyuki Tomita, Masatoshi Narahara, Hirokazu Kato
Life of this patent
Estimating the term…
Loading patent…
AssigneeHitachi, Ltd.
InventorsTakashi Yamamura, Jun-ichi Satoh, Toshiro Saito, Hiroyuki Tomita, Masatoshi Narahara, Hirokazu Kato
Estimating the term…
The efficacy of an interferon β treatment is evaluated by using a database on correlation between the efficacy of the interferon β treatment and the gene expression levels of at least one interferon induced protein gene, at least one interferon regulation factor gene, and at least one chemokine gene, and determining the expression levels of the genes in messenger RNAs derived from leukocytes in the peripheral blood of a subject.
An evaluation method of an interferon β treatment, comprising the steps of:
An oligonucleotide array for evaluating an interferon β treatment, comprising:
Dependencies are inferred from the claim text.